Company news
Devonian Health Group, Inc. news in 2026
Devonian Health Group, Inc.'s news releases, calls and decks from 2026, newest first.
Devonian Health Group Receives Health Canada Authorization to Evaluate Novel Thykamine(TM) Formulation for Prevention of Radiation-Induced Skin Injury in Breast Cancer Patients
October 20, 2026
Devonian Health Group Provides Update on its Planned NYSE American Listing
October 16, 2026
Devonian Health Group Inc. Anticipates to Commence Trading on the NYSE American
September 11, 2026
Devonian Health Group Strengthens Thykamine™ Manufacturing Platform with Validated Chemical-Composition Fingerprinting and Biological Potency Assay
September 1, 2026
Devonian Health Group Anticipates to Commence Trading on the NYSE American
August 18, 2026
Devonian Health Group Announces Proposed Listing on the NYSE American with Concurrent Underwritten Public Offering
July 26, 2026
Devonian Health Group Receives Health Canada Authorization to Initiate Phase II/III Pediatric Clinical Trial of Thykamine™ for Mild-to-Moderate Atopic Dermatitis in Patients Aged 3 Months to 17 Years
July 21, 2026
Devonian Health Group Reports Financial and Operating Results of its Three and Nine Months Ended April 30, 2026
June 29, 2026
Devonian Health Group Inc. Reports Financial and Operating Results of its Three and Six Months Ended January 31, 2026
March 25, 2026
Devonian Reports Human Liver-on-a-Chip Data Demonstrating Disease-Relevant Modulation of MASH by Thykamine(TM), with Dose-Dependent Anti-Fibrotic and Anti-Inflammatory Effects
February 19, 2026
Devonian Advances Thykamine(TM) Patent Strategy with Proprietary Fingerprint and Robust Manufacturing Controls
February 17, 2026
Devonian reports additional molecular data from MASH liver study
February 12, 2026
Devonian reports positive results in pulmonary fibrosis study
February 10, 2026
Devonian appoints Dennis Turpin as Chief Financial Officer and provides updates on stock options grant
February 2, 2026
Devonian announces share consolidation in further preparation for potential U.S. listing
January 20, 2026
Decks in 2026
- Investor Presentation (July 2026)
Investor deck · 27 slides · July 2026